Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading

被引:22
|
作者
Azorin, Jean-Michel [1 ]
Belzeaux, Raoul [1 ]
Adida, Marc [1 ]
机构
[1] St Marguerite Hosp, Dept Psychiat, F-13274 Marseille 9, France
关键词
History; Negative symptoms; Pathophysiology; Psychopathology; Schizophrenia; Treatment; DOUBLE-BLIND; RANDOMIZED-TRIAL; FEARFUL FACES; THERAPY; ANHEDONIA; AUGMENTATION; METAANALYSIS; ACTIVATION; CLOZAPINE; RESPONSES;
D O I
10.1111/cns.12292
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review traces the history of negative symptom profiles in neuropsychiatry from their earliest emergence in the 19th century to the current psychiatric concepts and therapeutic approaches. Recent investigations performing exploratory and confirmatory factor analysis have suggested that negative symptoms are multidimensional, including evidence for at least two distinct negative symptom subdomains: diminished expression and amotivation. Preliminary studies have demonstrated the clinical validity of this distinction. Several potential pathophysiological validating factors based on brain imaging analysis of emotional experiences and expressions in individuals with schizophrenia are examined. Finally, the potential of different treatment strategies, including medications and various psychotherapeutic techniques, to most favorably treat each of these subdomains is discussed.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 50 条
  • [41] NOTES™:: where have we been and where are we going?
    Hawes, Robert H.
    Rattner, David W.
    Fleischer, David
    Gostout, Christopher J.
    Kalloo, Anthony
    Kochman, Michael
    Marohn, Michael
    Ponsky, Jeffrey
    Rothstein, Richard
    Schwaitzberg, Steven
    Smith, C. Daniel
    Swanstrom, Lee
    Talamini, Mark
    Thompson, Christopher C.
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (06) : 779 - 780
  • [42] NEPA - WHERE HAVE WE BEEN AND WHERE ARE WE GOING
    LIROFF, RA
    JOURNAL OF THE AMERICAN PLANNING ASSOCIATION, 1980, 46 (02) : 154 - 161
  • [43] Medicare: Where have we been? Where are we going?
    Deeble, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1999, 23 (06) : 563 - 570
  • [44] Teleallergy: Where Have We Been and Where Are We Going?
    Ramsey, Allison
    Wu, Ann Chen
    Bender, Bruce G.
    Portnoy, Jay
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (01): : 126 - 131
  • [45] Membership: Where have we been, and where are we going?
    Schooler, Margaret J.
    CHEMICAL & ENGINEERING NEWS, 2017, 95 (27) : 32 - 32
  • [46] Where we have been, what we have learned and where we are going
    Heermann, DF
    NATIONAL IRRIGATION SYMPOSIUM, PROCEEDINGS, 2000, : 40 - 51
  • [47] Photoelectronics: Where have we been, and where are we going?
    Johnson, CB
    IMAGE INTENSIFIERS AND APPLICATIONS II, 2000, 4128 : 134 - 142
  • [48] Introduction: Where Are We Going, Where Have We Been?
    Heyne, Eric
    NORTHERN REVIEW, 2009, (31): : 5 - 7
  • [49] Neoplasia: Where we have been and where we are going
    Rehemtulla, Alnawaz
    NEOPLASIA, 2006, 8 (12): : 975 - 983
  • [50] Diagnosis of cardiac defects: where we have been, where we are, and where we are going
    Kilby, M
    Somerset, D
    PRENATAL DIAGNOSIS, 2003, 23 (01) : 80 - 81